TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Movement Assessment Battery for Children (M-ABC)-II
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of medication errors and adverse medication events
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of treatment delay or discontinuation due to treatment-emergent adverse events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Psychomotor processing speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-report symptoms of anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in vaginal pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Adult Body Mass Index (BMI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Offspring Body Mass Index (BMI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Offspring diet quality pre-post intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of Participants at Each Session
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Sessions Each Participant Completes
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Hours Participants Practice Mindfulness at Home
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in symptom severity
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Failed thrombolysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in Participant Functioning
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in Participant Health-related Quality of Life (HRQoL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Micheli Functional Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Roland morris disability questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Percentage of Participants Experiencing at Least One Treatment-Emergent Adverse Event
Endpoint domain: Adverse events/effects
Primary endpoint: Satisfaction assessed by the Visual Analog Scale in the palate
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Satisfaction assessed by analgesic pills consumption
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change of apnea hypopnea index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change of oxygen desaturation index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change of orthostatic hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of patients free from clinical ventricular arrhythmia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Potential Coverage
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Central Sensitization Inventory (CSI-I)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical grading of the facial skin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Mean specific simulated surgical competency assessment score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Variations in imaging features
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in metabolic feature
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean scores on the Mobile Health App Usability Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Total scores on the theoretical framework of acceptability questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Total scores on the Visual Analogue Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Total scores on Rollnick's Readiness Ruler
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Total Transition Readiness scores on the Successful Transition to Adulthood with Therapeutic = Rx Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Accumulation of plasticizers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of patients with serious diseases/conditions related to Covid-19
Endpoint domain: Mortality/survival
Primary endpoint: Daily symptoms improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to clinical symptom resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate and severity grade of adverse events related to the investigational product
Endpoint domain: Adverse events/effects
Primary endpoint: Percent change of Thyroid Peroxidase Antibodies (TPOAb)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in maximum distance walked
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative Quality of Recovery Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Life's Simple Seven (LS7) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change of Sleep Quality
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change of Comfort Level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change of Satisfaction Level
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Positive rate of patients diagnosed with definite monogenic obesity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Memory and Attention Phone Screener (MAPS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Taste disruption Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Smell disruption Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Brief Smell Identification Test (B-SIT) Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of mental and substance use disorders
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Complete remission rate (CR rate)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Cerebral Palsy Quality of Life (CPQoL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: 6- Minute Walk Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of hospitalizations at 18 months
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Proportion of patients achieving Mean Arterial Pressure above 65mm of Hg
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time to maintain target sedation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Volume of solution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tolerability of CGH bladder instillation
Endpoint domain: Adverse events/effects
Primary endpoint: Feasibility of CGH bladder instillation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiac burden
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Median Time to First Biochemical Relapse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fluorescence lifetime measurement of plaque inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cortico-subcortical electrophysiological coherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Participant Consent
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: 6-Month Follow Up Rate for PediRISE Program Group
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: 6-Month Follow Up Rate for Usual Care Group
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Hypoxia volume correlation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bruininks- Oseretsky Test of Motor Proficiency-2 (BOT-2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Childhood Executive Functioning Inventory
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Treatment-related severe adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Area Under the Serum Concentration Versus Time Curve from Time Zero to Infinity (AUC [0-Infinity])
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change Lipid Profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change Quality of Life Assessments
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change Serum Cortisol Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: The Things You Do Questionnaire - 21 item (TYD-Q)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Generalized Anxiety Disorder 7-Item (GAD-7)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Squat Jump (SJ) Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified 505 Change of Direction Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sprint 4 × 5 m Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified Agility T-Test (MAT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Running Jump Off Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acid exposure to the distal esophagus after intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Assessment of esophageal transit and gastric emptying
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Accuracy of deep learning model in assessing Mayo score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Mean change in distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum change in distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Volumetric changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with modified Rankin Score 0 to 3 on day 90
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Proportion of symptomatic intracranial hemorrhage (sICH)
Endpoint domain: Adverse events/effects
Primary endpoint: mTICI grade (<2 b、≥2 b) stratified for primary outcome analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Acute subjective effects
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Autonomic effects
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dexterity measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in ADHD symptoms - teacher report
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in ADHD symptoms - parent report
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in spatial working memory
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Incidence of postoperative pulmonary atelectasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of migraineurs patients with Platelet activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of migraineurs patients with high Thrombin generation levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: levels of the oxidative status in PFO patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of migraineurs patients with Untargeted metabolomics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Acute grade >2 hematological side effects
Endpoint domain: Adverse events/effects
Primary endpoint: Modified Dental Anxiety Scale Scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Oxygen saturation measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: HOOS Jr.
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Percentage of Participants With Unsolicited Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants With Medically Attended AEs (MAAEs), Serious Adverse Events (SAEs) and Adverse Events of Special Interest (AESI)
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants With Any Confirmed Relapse of Immune-mediated Disease (RA, IBD, or RRMS)
Endpoint domain: Adverse events/effects
Primary endpoint: Clinically significant haemorrhage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in Maximum Oxygen Consumption (Vo2max)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of patients with a skin graft performed before D21
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Area under plasma concentration time curve from zero to infinity (AUCinf) of Acalabrutinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration time curve from zero to the last quantifiable concentration (AUClast) of Acalabrutinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum observed plasma (peak) drug concentration (Cmax) of Acalabrutinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IL-6 Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence, type, and severity of Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Heart failure (HF) events
Endpoint domain: Mortality/survival
Primary endpoint: 36-Item Quality of Life (QoL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in serum Glutathione levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) pain questionnaire
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hounsfield unit of anchor tunnel
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diameter of anchor tunnel
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hounsfield unit of ossification site
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Posterior glenohumeral capsule elasticity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Posteroinferior glenohumeral capsule elasticity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Area under the curve (AUC), fasted state
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax, fasted state
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to accomplish tests with pelvic trainer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to accomplish tests with virtual reality simulator
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Knowledge Tests
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Perceived Learning Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Satisfaction Survey with Training Methods
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Creatinine Muscle Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Antibiotic Use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: PROMIS - Global Health
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Routine Assessment of Patient Index Data 3 (RAPID 3)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline autonomic response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline Trial Making Test (TMT) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spontaneous stone passage rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Complete Absence of Ocular Pain at Day 8
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Zero Cells on Day 14
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum CK Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum AST levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of opioid use disorder due to prolonged pain
Endpoint domain: Adverse events/effects
Primary endpoint: Risk of opioid use disorder due to prolonged opioid use
Endpoint domain: Adverse events/effects
Primary endpoint: Risk of opioid use disorder due to postoperative non-medical use of prescription opioids
Endpoint domain: Adverse events/effects
Primary endpoint: Risk of opioid use disorder due to increased rate of change in substance use
Endpoint domain: Adverse events/effects
Primary endpoint: Risk of opioid use disorder due to post-surgical trauma
Endpoint domain: Adverse events/effects
Primary endpoint: Variation in plasma concentration of cytokines IL-1β and IL-18
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence of Treatment-related SAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Protocol-specified AESIs
Endpoint domain: Adverse events/effects
Primary endpoint: Amplitude of gustatory evoked potentials
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Latency of the gustatory evoked potential
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: reward learning ability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain (VAS) in 7 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain (VAS) in 30 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain (VAS) in baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: functional deterioration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: score of Snaith-Hamilton Pleasure Scale, SHAPS
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Generalized Anxiety Disorder, GAD-7
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Patient Health Questionnaire, PHQ-9
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Functioning and disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Average Score for Quality of Life (QOL) Psychological Domain
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Total Score for Quality of Life (QOL) Social Domain
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Average Score for Quality of Life (QOL) Physical Domain
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Safety of the Bitrack System
Endpoint domain: Adverse events/effects
Primary endpoint: Performance of the Bitrack System
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total number of uterine contractions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trunk rotation angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Gait (walking speed)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Absolute power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Skin profilometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Proportion of patients with a history of cardiovascular events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Sensitivity and Specificity of I-ROP DL for mtmROP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Impedance variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes